Covid19 pneumonia is a rapidly developing disease with a high mortality rate . The main pathogenesis is the acute lung injury that causes ARDS (Acute respiratory contentment dText syndrome ) and death. Antioxidants should have a role in managing these conditions. Clinical studies and appropriate reports show that timely administration of Vit-C for high intravenous doses improves the outcome of Covid infection19.
Further detailed studies on the use of intravenous Vitamin C for the treatment of severe pneumonia infected with Covid19 are definitively justified. Covid19 could continue to show up in the future. Because the development of clinically active vaccines or antiviral drugs intended for specific diseases can take a long time to complete, the intravenous use of Vit-C as a universal agent for ARDS may have benefits for Covid19. Further clinical studies on IV Vit-C and oral VC (like the liposomal encapsulated VC) addressed to other situations through different mechanisms are necessary to develop as soon as possible.”
To read the text of scientific research, click here click here